MediWound (MDWD) Total Liabilities (2013 - 2026)
MediWound (MDWD) posted Total Liabilities of $36.2 million for Q2 2026, down 6.03% on a QoQ basis from $38.6 million in Q1 2026, and down 22.71% year-over-year from $46.9 million in Q2 2025.
Analysis
MediWound (MDWD) Total Liabilities (2013 - 2026) Analysis & Trends
MediWound has reported Total Liabilities for 14 years, with the latest figure at $36.2 million in Q2 2026.
- On a quarterly basis, Total Liabilities fell 22.71% year-over-year to $36.2 million in Q2 2026; TTM through Jun 2026 was $36.2 million, a 22.71% decrease from a year earlier, with the FY2025 full-year figure at $42.6 million, up 0.66% from the prior year.
- Total Liabilities was $36.2 million for Q2 2026 at MediWound, down from $38.6 million in the prior quarter.
- The five-year high for Total Liabilities was $46.9 million in Q2 2025, with the low at $23.3 million in Q2 2022.
- Average Total Liabilities over 5 years is $36.4 million, with a median of $38.2 million recorded in 2025.
- The sharpest annual moves came in 2022 and 2026: Total Liabilities jumped 60.74% in 2022, then declined 22.71% in 2026.
- Over 5 years, Total Liabilities stood at $39.1 million in 2022, then dropped by 10.84% to $34.9 million in 2023, then increased by 21.45% to $42.3 million in 2024, then advanced by 0.66% to $42.6 million in 2025, then declined by 14.99% to $36.2 million in 2026.
- The last three Total Liabilities figures came in at $36.2 million (Q2 2026), $38.6 million (Q1 2026), and $42.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 83.95 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 37.53 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 7.18 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 10.02 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 1.62 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 4.20 Bn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 4.20 Bn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 13.24 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 384.62 Mn |
| 10 | MediWound | 156.09 Mn | 120.75 Mn | 337,000.00 | 36.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 36.24 Mn |
| Mar 31, 2026 | 38.56 Mn |
| Dec 31, 2025 | 42.62 Mn |
| Sep 30, 2025 | 44.27 Mn |
| Jun 30, 2025 | 46.88 Mn |
| Mar 31, 2025 | 37.74 Mn |
| Dec 31, 2024 | 42.34 Mn |
| Sep 30, 2024 | 40.50 Mn |
| Jun 30, 2024 | 39.43 Mn |
| Mar 31, 2024 | 39.18 Mn |
| Dec 31, 2023 | 34.86 Mn |
| Sep 30, 2023 | 33.97 Mn |
| Jun 30, 2023 | 29.44 Mn |
| Mar 31, 2023 | 35.37 Mn |
| Dec 31, 2022 | 39.10 Mn |
| Sep 30, 2022 | 26.93 Mn |
| Jun 30, 2022 | 23.34 Mn |
| Mar 31, 2022 | 24.42 Mn |
| Dec 31, 2021 | 24.33 Mn |
| Sep 30, 2021 | 23.99 Mn |